Brookstone Capital Management Sells 529,264 Shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBA)

Brookstone Capital Management decreased its holdings in Walgreens Boots Alliance, Inc. (NASDAQ:WBA) by 94.8% in the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 29,157 shares of the pharmacy operator’s stock after selling 529,264 shares during the period. Brookstone Capital Management’s holdings in Walgreens Boots Alliance were worth $632,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also modified their holdings of the company. Fulton Bank N.A. grew its holdings in shares of Walgreens Boots Alliance by 0.5% in the fourth quarter. Fulton Bank N.A. now owns 107,071 shares of the pharmacy operator’s stock worth $2,796,000 after acquiring an additional 523 shares during the period. Insight Folios Inc grew its holdings in shares of Walgreens Boots Alliance by 5.8% in the fourth quarter. Insight Folios Inc now owns 9,640 shares of the pharmacy operator’s stock worth $252,000 after acquiring an additional 525 shares during the period. Atlas Brown Inc. grew its holdings in shares of Walgreens Boots Alliance by 1.8% in the first quarter. Atlas Brown Inc. now owns 31,593 shares of the pharmacy operator’s stock worth $685,000 after acquiring an additional 550 shares during the period. Pinnacle Financial Partners Inc grew its holdings in shares of Walgreens Boots Alliance by 4.9% in the fourth quarter. Pinnacle Financial Partners Inc now owns 11,866 shares of the pharmacy operator’s stock worth $310,000 after acquiring an additional 555 shares during the period. Finally, Westpac Banking Corp grew its holdings in shares of Walgreens Boots Alliance by 10.1% in the fourth quarter. Westpac Banking Corp now owns 6,100 shares of the pharmacy operator’s stock worth $159,000 after acquiring an additional 560 shares during the period. Institutional investors own 58.59% of the company’s stock.

Walgreens Boots Alliance Trading Down 0.7 %

Shares of WBA stock opened at $12.10 on Monday. Walgreens Boots Alliance, Inc. has a 12-month low of $11.68 and a 12-month high of $31.32. The company has a current ratio of 0.65, a quick ratio of 0.32 and a debt-to-equity ratio of 0.49. The stock’s 50-day moving average price is $16.49 and its 200-day moving average price is $20.14. The stock has a market capitalization of $10.44 billion, a price-to-earnings ratio of -1.80, a price-to-earnings-growth ratio of 0.84 and a beta of 0.78.

Walgreens Boots Alliance (NASDAQ:WBA) last issued its quarterly earnings data on Thursday, June 27th. The pharmacy operator reported $0.63 earnings per share for the quarter, missing the consensus estimate of $0.68 by ($0.05). Walgreens Boots Alliance had a positive return on equity of 12.63% and a negative net margin of 3.99%. The company had revenue of $36.40 billion for the quarter, compared to the consensus estimate of $35.94 billion. During the same period in the previous year, the firm earned $1.00 earnings per share. The company’s revenue was up 2.8% compared to the same quarter last year. Equities research analysts predict that Walgreens Boots Alliance, Inc. will post 2.94 EPS for the current fiscal year.

Walgreens Boots Alliance Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Wednesday, June 12th. Stockholders of record on Tuesday, May 21st were paid a dividend of $0.25 per share. The ex-dividend date of this dividend was Monday, May 20th. This represents a $1.00 dividend on an annualized basis and a dividend yield of 8.26%. Walgreens Boots Alliance’s dividend payout ratio is -14.84%.

Analyst Upgrades and Downgrades

WBA has been the subject of several research analyst reports. Truist Financial cut their price objective on Walgreens Boots Alliance from $20.00 to $13.00 and set a “hold” rating for the company in a report on Friday. UBS Group lowered their target price on Walgreens Boots Alliance from $22.00 to $17.00 and set a “neutral” rating on the stock in a research report on Monday, June 24th. Bank of America reiterated an “underperform” rating and set a $11.00 target price (down from $22.00) on shares of Walgreens Boots Alliance in a research report on Friday. SVB Leerink lowered their target price on Walgreens Boots Alliance from $23.00 to $22.00 and set a “market perform” rating on the stock in a research report on Monday, March 18th. Finally, Raymond James reiterated a “market perform” rating on shares of Walgreens Boots Alliance in a research report on Tuesday, March 26th. Four investment analysts have rated the stock with a sell rating, eleven have assigned a hold rating and two have given a buy rating to the stock. According to data from MarketBeat, the stock presently has an average rating of “Hold” and an average target price of $20.64.

Insider Activity

In other Walgreens Boots Alliance news, CFO Manmohan Mahajan bought 6,000 shares of the business’s stock in a transaction dated Tuesday, April 2nd. The shares were purchased at an average price of $19.38 per share, with a total value of $116,280.00. Following the completion of the purchase, the chief financial officer now owns 166,969 shares in the company, valued at approximately $3,235,859.22. The purchase was disclosed in a filing with the SEC, which is accessible through this hyperlink. In other Walgreens Boots Alliance news, CFO Manmohan Mahajan bought 6,000 shares of the business’s stock in a transaction dated Tuesday, April 2nd. The shares were purchased at an average price of $19.38 per share, with a total value of $116,280.00. Following the completion of the purchase, the chief financial officer now owns 166,969 shares in the company, valued at approximately $3,235,859.22. The purchase was disclosed in a filing with the SEC, which is accessible through this hyperlink. Also, Director Inderpal S. Bhandari purchased 3,000 shares of the stock in a transaction that occurred on Thursday, April 11th. The stock was purchased at an average price of $18.05 per share, with a total value of $54,150.00. Following the acquisition, the director now directly owns 3,000 shares of the company’s stock, valued at approximately $54,150. The disclosure for this purchase can be found here. Insiders own 17.40% of the company’s stock.

About Walgreens Boots Alliance

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.